Dentsply International Inc. (NASDAQ:XRAY) gapped up prior to trading on Wednesday . The stock had previously closed at $62.68, but opened at $62.81. Dentsply International shares last traded at $63.35, with a volume of 364,836 shares changing hands.

A number of equities research analysts have recently commented on XRAY shares. Piper Jaffray Cos. started coverage on shares of Dentsply International in a research report on Monday, June 13th. They issued an “overweight” rating and a $70.00 target price for the company. Morgan Stanley cut shares of Dentsply International from an “overweight” rating to an “equal weight” rating and set a $65.00 target price for the company. in a research report on Thursday, March 24th. Credit Suisse Group AG reiterated a “buy” rating on shares of Dentsply International in a research report on Sunday, June 5th. Zacks Investment Research upgraded shares of Dentsply International from a “sell” rating to a “hold” rating in a research report on Tuesday, April 5th. Finally, Barrington Research reiterated an “outperform” rating and issued a $68.00 target price (up from $62.00) on shares of Dentsply International in a research report on Friday, May 13th. One research analyst has rated the stock with a sell rating, three have given a hold rating and eight have given a buy rating to the company’s stock. Dentsply International currently has a consensus rating of “Buy” and a consensus price target of $66.50.

The company has a market capitalization of $14.81 billion and a P/E ratio of 30.74. The firm has a 50-day moving average of $62.92 and a 200 day moving average of $60.53.

Dentsply International (NASDAQ:XRAY) last posted its quarterly earnings data on Friday, May 6th. The company reported $0.69 earnings per share for the quarter, topping the consensus estimate of $0.63 by $0.06. During the same period in the prior year, the company earned $0.59 earnings per share. The firm had revenue of $772.60 million for the quarter, compared to analyst estimates of $741.80 million. The firm’s quarterly revenue was up 17.7% on a year-over-year basis. On average, equities research analysts forecast that Dentsply International Inc. will post $2.75 EPS for the current year.

In other news, Director Michael C. Alfano sold 3,000 shares of the company’s stock in a transaction dated Thursday, May 26th. The stock was sold at an average price of $61.58, for a total transaction of $184,740.00. Following the completion of the transaction, the director now directly owns 8,758 shares of the company’s stock, valued at $539,317.64. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, VP Rainer Berthan sold 6,464 shares of the company’s stock in a transaction dated Thursday, June 2nd. The stock was sold at an average price of $62.56, for a total value of $404,387.84. Following the transaction, the vice president now directly owns 39,341 shares of the company’s stock, valued at $2,461,172.96. The disclosure for this sale can be found here.

Several hedge funds and institutional investors have recently bought and sold shares of XRAY. Advisors Asset Management Inc. boosted its position in Dentsply International by 4.2% in the fourth quarter. Advisors Asset Management Inc. now owns 24,738 shares of the company’s stock valued at $1,505,000 after buying an additional 992 shares in the last quarter. BOKF NA boosted its position in Dentsply International by 6.2% in the fourth quarter. BOKF NA now owns 19,194 shares of the company’s stock valued at $1,168,000 after buying an additional 1,114 shares in the last quarter. GAM Holding AG boosted its position in Dentsply International by 15.0% in the fourth quarter. GAM Holding AG now owns 26,643 shares of the company’s stock valued at $1,621,000 after buying an additional 3,482 shares in the last quarter. Aberdeen Asset Management PLC UK boosted its position in Dentsply International by 18.2% in the fourth quarter. Aberdeen Asset Management PLC UK now owns 25,917 shares of the company’s stock valued at $1,519,000 after buying an additional 3,982 shares in the last quarter. Finally, Bank of Montreal Can boosted its position in Dentsply International by 20.8% in the fourth quarter. Bank of Montreal Can now owns 36,573 shares of the company’s stock valued at $2,223,000 after buying an additional 6,297 shares in the last quarter.

DENTSPLY SIRONA Inc, formerly DENTSPLY International Inc, designs, develops, manufactures and markets a range of consumable dental products for the professional dental market. The Company also manufactures and markets consumable medical device products consisting mainly of urological catheters and certain surgical products.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.